吉林大学学报(医学版) ›› 2019, Vol. 45 ›› Issue (02): 286-293.doi: 10.13481/j.1671-587x.20190213

• 基础研究 • 上一篇    

人参糖肽的结构及其对Aβ25-35处理PC12细胞的抗凋亡作用

胡婧婷1, 邱智东1,2, 朱迪夫3, 陈英红4, 姜瑞芝3,4, 贺明5, 罗浩铭1,2   

  1. 1. 长春中医药大学药学院中药药剂实验室, 吉林 长春 130117;
    2. 长春中医药大学药学院 中药有效成分教育部重点实验室, 吉林 长春 130117;
    3. 吉林省吉测检测技术有限公司研发部, 吉林 长春 130117;
    4. 吉林省中医药科学院中医药基础所, 吉林 长春 130012;
    5. 河北中医学院中西医结合学院 河北省中西医结合肝肾病证研究重点实验室, 河北 石家庄 050200
  • 收稿日期:2018-11-06 发布日期:2019-03-29
  • 通讯作者: 罗浩铭,副教授,硕士研究生导师(Tel:0431-86172555,E-mail:luo.haoming@163.com);贺明,副教授,硕士研究生导师(Tel:0311-89926292,E-mail:heming200195@163.com) E-mail:luo.haoming@163.com;heming200195@163.com
  • 作者简介:胡婧婷(1992-),女,吉林省磐石市人,在读中药学硕士,主要从事中药药剂学方面的研究。
  • 基金资助:
    吉林省科技厅优秀青年人才基金项目资助课题(20180520056JH);吉林省科技厅科技发展计划项目资助课题(20180623037TC);吉林省高校科技与社科"十三五"科研规划项目资助课题(JJKH20190474KJ)

Structures of ginseng glycopeptides and anti-apoptotic effect on PC12 cells treated with Aβ25-35

HU Jingting1, QIU Zhidong1,2, ZHU Difu3, CHEN Yinghong4, JIANG Ruizhi3,4, HE Ming5, LUO Haoming1,2   

  1. 1. Laboratory of Chinese Medicine, School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China;
    2. Key Laboratory of Effective Components of Traditional Chinese Medicine, Ministry of Education, School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China;
    3. Department Research and Development, Jilin Jice Inspection Technology Co., Ltd., Changchun 130117, China;
    4. Institute of Traditional Chinese Medicine, Jilin Academy of Chinese Medicine and Material Medicaly Sciences, Changchun 130117, China;
    5. Hebei Key Laboratory of Integrated Traditional Chinese and Western Medicine for Hepatorenal Diseases, College of Integrated Traditional Chinese and Western Medicine, Hebei University of Traditional Chinese Medicine, Shijiazhuang 050200, China
  • Received:2018-11-06 Published:2019-03-29

摘要: 目的:研究人参糖肽的结构,探讨其对β淀粉样蛋白25-35(Aβ25-35)处理PC12细胞凋亡的保护作用,为开发人参抗阿尔茨海默病(AD)药物奠定理论基础。方法:采用反相高效液相色谱法(RP-HPLC)与Q ExactiveOrbitrap质谱联用分析人参糖肽结构。将鼠嗜铬细胞瘤PC12细胞分为6组,加入含不同浓度(0、6.25、12.50、25.00、50.00和100.00 μmol·L-1) Aβ25-35的培养基,采用细胞计数试剂盒8(CCK-8)法测定PC12细胞的存活率。将PC12细胞分为空白对照组、模型组和给药组,模型组加入含有50.00 μmol·L-125-35的培养基,给药组加入不同浓度(0.03、0.10、0.30和1.00 g·L-1)人参糖肽和含有50.00 μmol·L-125-35的培养基。采用CCK-8法测定PC12细胞的存活率,采用Annexin Ⅴ-FITC/PI法测定人参糖肽和Aβ25-35处理后PC12细胞的凋亡率。将PC12细胞分为空白对照组、模型组和人参糖肽给药组,模型组加入含有50.00 μmol·L-125-35的培养基,给药组加入不同浓度(0.10和0.30 g·L-1)人参糖肽和含有50.00 μmol·L-125-35的培养基,采用流式细胞术测定不同细胞周期PC12细胞的百分比。结果:人参糖肽结构分析得到肽链为NLSHYHSGSS、糖基为N1-HexNAc,肽链为SGSSSSSSSEDDGMGR、糖基为S6-HexNAc等20多个人参糖肽结构。当Aβ25-35浓度为50 μmol·L-1时,PC12细胞存活率为(55.45±2.34)%;与空白对照组比较,不同浓度Aβ25-35处理组PC12细胞存活率明显降低(P<0.01)。与空白对照组比较,模型组PC12细胞存活率明显降低(P<0.01);与模型组比较,给药组细胞存活率明显升高(P<0.05)。与空白对照组比较,模型组PC12细胞凋亡率升高(P<0.01);与模型组比较,给药组细胞凋亡率降低(P<0.05)。与空白对照组比较,模型组S期PC12细胞百分比升高(P<0.05);与模型组比较,给药组S期PC12细胞百分比降低(P<0.05)。结论:利用质谱法分析得到人参糖肽结构。人参糖肽可有效抑制Aβ25-35处理PC12细胞的凋亡,具有神经细胞保护作用,其抗凋亡活性作用可能与抑制细胞S期阻滞有关。

关键词: 人参, 糖肽, 细胞凋亡, 细胞周期, β-淀粉样蛋白

Abstract: Objective: To study the structures of ginseng glycopeptides, and to explore the protective effect on the apoptosis of PC12 cells treated with amyloid beta25-35 (Aβ25-35), and to lay a theoretical foundation for the development of ginseng anti-Alzheimer's disease(AD)drugs.Methods: The structures of ginseng glycopeptides were analyzed by reversed-phase high performance liquid chromatography coupled with Q Exactive Orbitrap mass spectrometry. The PC12 cells were divided into 6 groups, and treated with the medium including different concentrations (0, 6.25, 12.50, 25.00, 50.00, and 100.00 μmol·L-1) of Aβ25-35, and the survival rates of PC12 cells were measured by cell counting kit-8(CCK-8) method. The PC12 cells were divided into blank control group, model group,and ginseng glycopeptides administration group.The medium including 50.00 μmol·L-125-35 was added in model group,and different concentrations (0.03,0.10,0.30,and of 1.00 g·L-1) ginseng glycopeptides+ 50 μmol·L-125-35were added in administration groups.The survival rates of PC12 cells were measured by CCK-8 method. The apoptotic rates of PC12 cells after treated with glycopeptides and Aβ25-35 were detected by Annexin Ⅴ-FITC/PI method. The PC12 cells were divided into blank control group, model group (50.00 μmol·L-125-35) and different concentrations (0.10 and 0.30 g·L-1) of ginseng glycopeptides administration groups;the percentages of PC12 cells in different cell cycles were tested by flow cytometry.Results: More than 20 glycopeptide structures were obtained, such as the peptide chain was NLSHYHSGSS, the glycosyl group was N1-HexNAc, and the peptide chain was SGSSSSSSSEDDGMGR, the glycosyl group was S6-HexNAc. When the concentration of Aβ25-35 was 50 μmol·L-1, the survival rate of PC12 was (55.45±2.34)% and the survival rate was significantly lower than that in blank control group (P<0.01). Compared with blank control group, the survival rate of the PC12 cells in model group was significantly decreased (P<0.01);compared with model group, the survival rates of the PC12 cells in administration groups were significantly increased (P<0.05). Compared with blank control group, the apoptotic rate of the PC12 cells in model group were increased (P<0.01);compared with model group, the apoptotic rates of the PC12 cells in administration groups were decreased (P<0.05).Compared with blank control group, the percentage of PC12 cells in S phase in model group was increased(P<0.05);compared with model group, the percentages of PC12 cells in S phase in administration groups were decreased (P<0.05).Conclusion: The structures of ginseng glycopeptides are obtained with mass spectrometry. Ginseng glycopeptides can effectively inhibit the apoptosis of PC12 cells treated with Aβ25-35, and they have the neuroprotective effect;the anti-apoptotic activity effect may be related to the inhibition of S phase arrest.

Key words: Panax ginseng, glycopeptide, apoptosis, cell cycle, amyloid beta

中图分类号: 

  • R285.5